Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 10.94 Billion DKK | 14.57% |
| 2023 | 9.55 Billion DKK | 10.02% |
| 2022 | 8.61 Billion DKK | 23.87% |
| 2021 | 6.95 Billion DKK | 2.96% |
| 2020 | 6.75 Billion DKK | 2.44% |
| 2019 | 6.59 Billion DKK | 10.41% |
| 2018 | 5.97 Billion DKK | 7.72% |
| 2017 | 5.54 Billion DKK | 6.96% |
| 2016 | 5.18 Billion DKK | 3.76% |
| 2015 | 4.99 Billion DKK | 13.82% |
| 2014 | 4.39 Billion DKK | 4.7% |
| 2013 | 4.19 Billion DKK | 2.54% |
| 2012 | 4.09 Billion DKK | 2.58% |
| 2011 | 3.98 Billion DKK | 5.87% |
| 2010 | 3.76 Billion DKK | 1.56% |
| 2009 | 3.7 Billion DKK | -2.45% |
| 2008 | 3.8 Billion DKK | -28.93% |
| 2007 | 5.34 Billion DKK | 30.98% |
| 2006 | 4.08 Billion DKK | 47.77% |
| 2005 | 2.76 Billion DKK | 6.08% |
| 2004 | 2.6 Billion DKK | 0.91% |
| 2003 | 2.58 Billion DKK | 3.45% |
| 2002 | 2.49 Billion DKK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.68 Billion DKK | 10.92% |
| 2024 Q3 | 2.79 Billion DKK | 4.34% |
| 2024 Q2 | 2.69 Billion DKK | 0.56% |
| 2023 FY | 9.48 Billion DKK | 10.02% |
| 2023 Q2 | 2.35 Billion DKK | -0.67% |
| 2023 Q1 | 2.37 Billion DKK | 0.68% |
| 2023 Q4 | 2.41 Billion DKK | 3.47% |
| 2023 Q3 | 2.33 Billion DKK | -0.81% |
| 2022 Q1 | 1.88 Billion DKK | 0.53% |
| 2022 FY | 8.61 Billion DKK | 23.87% |
| 2022 Q4 | 2.35 Billion DKK | 3.02% |
| 2022 Q3 | 2.28 Billion DKK | 9.16% |
| 2022 Q2 | 2.09 Billion DKK | 11.38% |
| 2021 FY | 6.95 Billion DKK | 2.96% |
| 2021 Q1 | 1.67 Billion DKK | -1.07% |
| 2021 Q2 | 1.67 Billion DKK | 0.24% |
| 2021 Q3 | 1.74 Billion DKK | 4.12% |
| 2021 Q4 | 1.87 Billion DKK | 7.34% |
| 2020 Q4 | 1.68 Billion DKK | 5.37% |
| 2020 Q3 | 1.6 Billion DKK | -7.29% |
| 2020 Q1 | 1.74 Billion DKK | 2.9% |
| 2020 FY | 6.75 Billion DKK | 2.44% |
| 2020 Q2 | 1.72 Billion DKK | -0.69% |
| 2019 Q3 | 1.68 Billion DKK | 4.33% |
| 2019 FY | 6.59 Billion DKK | 10.41% |
| 2019 Q1 | 1.6 Billion DKK | 8.51% |
| 2019 Q2 | 1.61 Billion DKK | 0.56% |
| 2019 Q4 | 1.69 Billion DKK | 0.36% |
| 2018 FY | 5.97 Billion DKK | 7.72% |
| 2018 Q1 | 1.45 Billion DKK | 4.36% |
| 2018 Q4 | 1.48 Billion DKK | -3.96% |
| 2018 Q3 | 1.54 Billion DKK | 3.08% |
| 2018 Q2 | 1.49 Billion DKK | 2.47% |
| 2017 Q4 | 1.39 Billion DKK | -1.48% |
| 2017 Q3 | 1.41 Billion DKK | 3.13% |
| 2017 Q1 | 1.35 Billion DKK | 6.03% |
| 2017 FY | 5.54 Billion DKK | 6.96% |
| 2017 Q2 | 1.37 Billion DKK | 1.62% |
| 2016 FY | 5.18 Billion DKK | 3.76% |
| 2016 Q2 | 1.28 Billion DKK | -1.98% |
| 2016 Q3 | 1.31 Billion DKK | 1.94% |
| 2016 Q1 | 1.31 Billion DKK | 3.8% |
| 2016 Q4 | 1.27 Billion DKK | -2.59% |
| 2015 Q3 | 1.32 Billion DKK | 8.09% |
| 2015 FY | 4.99 Billion DKK | 13.82% |
| 2015 Q1 | 1.18 Billion DKK | 4.67% |
| 2015 Q2 | 1.22 Billion DKK | 3.12% |
| 2015 Q4 | 1.26 Billion DKK | -4.46% |
| 2014 Q1 | 1.08 Billion DKK | 2.27% |
| 2014 Q3 | 1.09 Billion DKK | 0.65% |
| 2014 FY | 4.39 Billion DKK | 4.7% |
| 2014 Q4 | 1.13 Billion DKK | 3.85% |
| 2014 Q2 | 1.08 Billion DKK | 0.46% |
| 2013 Q1 | 1.03 Billion DKK | 1.18% |
| 2013 FY | 4.19 Billion DKK | 2.54% |
| 2013 Q4 | 1.05 Billion DKK | -1.31% |
| 2013 Q3 | 1.07 Billion DKK | 3.38% |
| 2013 Q2 | 1.03 Billion DKK | 0.19% |
| 2012 Q3 | 1.01 Billion DKK | 1.39% |
| 2012 Q4 | 1.02 Billion DKK | 0.2% |
| 2012 Q2 | 1 Billion DKK | -3.83% |
| 2012 FY | 4.09 Billion DKK | 2.58% |
| 2012 Q1 | 1.04 Billion DKK | 8.18% |
| 2011 Q2 | 1 Billion DKK | 0.3% |
| 2011 Q1 | 999 Million DKK | 0.91% |
| 2011 FY | 3.98 Billion DKK | 5.87% |
| 2011 Q3 | 1.02 Billion DKK | 1.8% |
| 2011 Q4 | 966 Million DKK | -5.29% |
| 2010 Q1 | 900 Million DKK | -3.54% |
| 2010 FY | 3.76 Billion DKK | 1.56% |
| 2010 Q4 | 990 Million DKK | 3.88% |
| 2010 Q3 | 953 Million DKK | 3.25% |
| 2010 Q2 | 923 Million DKK | 2.56% |
| 2009 Q2 | 859 Million DKK | -10.71% |
| 2009 Q1 | 962 Million DKK | 0.0% |
| 2009 FY | 3.7 Billion DKK | -2.45% |
| 2009 Q4 | 933 Million DKK | -2.2% |
| 2009 Q3 | 954 Million DKK | 11.06% |
| 2008 FY | 3.8 Billion DKK | -28.93% |
| 2007 FY | 5.34 Billion DKK | 30.98% |
| 2006 FY | 4.08 Billion DKK | 47.77% |
| 2005 FY | 2.76 Billion DKK | 6.08% |
| 2004 FY | 2.6 Billion DKK | 0.91% |
| 2003 FY | 2.58 Billion DKK | 3.45% |
| 2002 FY | 2.49 Billion DKK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -382287.342% |
| Ansell Limited | 495.5 Million USD | -2109.687% |
| Ansell Limited | 495.5 Million USD | -2109.687% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -13122.826% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -632513.725% |
| Psykey, Inc. | 1.21 Million USD | -902181.043% |
| ConvaTec Group Plc | 910.31 Million USD | -1102.769% |
| ConvaTec Group Plc | 872.5 Million USD | -1154.9% |
| Encision Inc. | 3.77 Million USD | -289805.726% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -7720739.709% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -9959783.927% |
| Innovative MedTech Inc. | 6.09 Million USD | -179421.204% |
| LifePoint, Inc. | 7.42 Million USD | -147383.725% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -172352.355% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -1280484.795% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -1507748.414% |
| Reflect Scientific, Inc. | 1.06 Million USD | -1029232.546% |
| SmileDirectClub, Inc. | 517 Million USD | -2017.783% |
| Sector 10, Inc. | 39.84 Thousand USD | -27479570.716% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -64.819% |
| SheerVision, Inc. | 2.33 Million USD | -469484.648% |
| United Health Products, Inc. | 2.42 Million USD | -451118.794% |
| Vasamed, Inc. | 4.67 Million USD | -234207.757% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -427294.133% |
| Yubo International Biotech Limited | 1.25 Million USD | -870336.252% |